Total Payments
$39,283
2024 Payments
$1,430
Companies
26
Transactions
203
Medicare Patients
7,351
Medicare Billing
$311,535
Payment Breakdown by Category
Consulting$15,938 (40.6%)
Travel$14,391 (36.6%)
Food & Beverage$8,786 (22.4%)
Education$168.57 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $15,938 | 1 | 40.6% |
| Travel and Lodging | $14,391 | 43 | 36.6% |
| Food and Beverage | $8,786 | 158 | 22.4% |
| Education | $168.57 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $15,938 | 1 | $0 (2023) |
| Eli Lilly and Company | $13,314 | 43 | $0 (2023) |
| Abbott Laboratories | $2,357 | 24 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,955 | 23 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $1,168 | 12 | $0 (2019) |
| ABIOMED | $625.64 | 10 | $0 (2024) |
| Gilead Sciences, Inc. | $597.41 | 5 | $0 (2019) |
| Medtronic Vascular, Inc. | $532.64 | 5 | $0 (2018) |
| Amgen Inc. | $500.75 | 16 | $0 (2022) |
| Novo Nordisk Inc | $474.62 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,430 | 16 | Novartis Pharmaceuticals Corporation ($749.76) |
| 2023 | $30,409 | 63 | Edwards Lifesciences Corporation ($15,938) |
| 2022 | $1,035 | 11 | Novartis Pharmaceuticals Corporation ($407.49) |
| 2021 | $662.52 | 10 | Abbott Laboratories ($269.39) |
| 2020 | $11.17 | 1 | Boston Scientific Corporation ($11.17) |
| 2019 | $1,204 | 14 | Merck Sharp & Dohme Corporation ($597.47) |
| 2018 | $2,721 | 41 | Abbott Laboratories ($1,107) |
| 2017 | $1,810 | 47 | Abbott Laboratories ($529.80) |
All Payment Transactions
203 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $41.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $104.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $87.49 | General |
| Category: Cardio-renal | ||||||
| 09/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Obesity | ||||||
| 08/30/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $138.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $60.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $133.50 | General |
| Category: Obesity | ||||||
| 06/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $42.16 | General |
| Category: Obesity | ||||||
| 05/28/2024 | Ancora Heart, Inc. | AccuCinch (Device) | Food and Beverage | Cash or cash equivalent | $131.51 | General |
| Category: Cardiovascular | ||||||
| 05/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $8.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/26/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $70.13 | General |
| 04/20/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $203.81 | General |
| 04/20/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $171.35 | General |
| 04/19/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $140.00 | General |
| 02/14/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/25/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $45.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/21/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $54.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/14/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $83.95 | General |
| Category: Obesity | ||||||
| 12/08/2023 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Consulting Fee | Cash or cash equivalent | $15,937.50 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/16/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: Obesity | ||||||
| 10/28/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $106.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2023 | Terumo Medical Corporation | ANGIO-SEAL (Device), GLIDEWIRE, TR BAND | Food and Beverage | In-kind items and services | $39.90 | General |
| Category: VASCULAR ACCESS | ||||||
| 09/07/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $73.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $30.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/18/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $35.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,977 | 2,272 | $472,302 | $82,176 |
| 2022 | 24 | 2,634 | 3,137 | $629,445 | $110,252 |
| 2021 | 22 | 2,246 | 2,709 | $536,458 | $101,264 |
| 2020 | 10 | 494 | 553 | $92,335 | $17,843 |
Total Patients
7,351
Total Services
8,671
Medicare Billing
$311,535
Procedure Codes
109
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 267 | 270 | $86,940 | $15,009 | 17.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 96 | 154 | $66,220 | $11,987 | 18.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 90 | $40,860 | $9,182 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 101 | $43,430 | $7,976 | 18.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 51 | 51 | $49,182 | $7,151 | 14.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 580 | 671 | $24,827 | $4,524 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 51 | $14,841 | $2,738 | 18.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 38 | 46 | $13,386 | $2,310 | 17.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 32 | $10,420 | $2,171 | 20.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $9,904 | $1,827 | 18.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 12 | $10,584 | $1,785 | 16.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $8,358 | $1,559 | 18.7% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 17 | 17 | $8,177 | $1,452 | 17.8% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 25 | 25 | $8,100 | $1,403 | 17.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 107 | 107 | $11,021 | $1,323 | 12.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $7,700 | $1,256 | 16.3% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2023 | 17 | 17 | $7,124 | $1,087 | 15.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 46 | 46 | $4,554 | $816.30 | 17.9% |
| 93352 | Injection of x-ray contrast during ultrasound of heart | Facility | 2023 | 25 | 25 | $4,450 | $757.68 | 17.0% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 34 | 35 | $4,130 | $744.10 | 18.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 41 | 41 | $3,403 | $592.02 | 17.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 50 | 50 | $3,250 | $585.06 | 18.0% |
| 93352 | Injection of x-ray contrast during ultrasound of heart | Office | 2023 | 17 | 17 | $3,026 | $473.55 | 15.6% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 47 | 48 | $5,937 | $450.34 | 7.6% |
| 93790 | Ambulatory blood pressure monitoring, 1 day or longer, with review, interpretation and report | Facility | 2023 | 25 | 26 | $2,130 | $403.00 | 18.9% |
About Dr. Andy Lee, MD
Dr. Andy Lee, MD is a Cardiovascular Disease healthcare provider based in Orange, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2013. The National Provider Identifier (NPI) number assigned to this provider is 1013250463.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andy Lee, MD has received a total of $39,283 in payments from pharmaceutical and medical device companies, with $1,430 received in 2024. These payments were reported across 203 transactions from 26 companies. The most common payment nature is "Consulting Fee" ($15,938).
As a Medicare-enrolled provider, Lee has provided services to 7,351 Medicare beneficiaries, totaling 8,671 services with total Medicare billing of $311,535. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Orange, CA
- Active Since 04/04/2013
- Last Updated 01/21/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1013250463
Products in Payments
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $15,938
- MK-1242 (Drug) $1,168
- LEQVIO (Drug) $734.54
- CardioMEMS HF System (Device) $717.89
- ENTRESTO (Drug) $634.85
- Impella (Device) $625.64
- ELIQUIS (Drug) $482.08
- Circulatory Support (Device) $445.02
- Repatha (Biological) $338.37
- Wegovy (Drug) $310.07
- HeartMate (Device) $294.07
- HeartMate 3 Left Ventricular Assist Device (Device) $269.39
- GENERAL - THERAPIES (Device) $219.55
- BRILINTA (Drug) $172.97
- Ensite Cardiac Mapping System (Device) $168.57
- Ozempic (Drug) $164.55
- Corlanor (Drug) $162.38
- Kerendia (Drug) $160.43
- Xience Alpine cornary stent system (Device) $159.22
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $149.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Orange
Morton Kern, Md, MD
Cardiovascular Disease — Payments: $411,795
Cardiovascular Disease $411,795
Michael Chan, M.d, M.D
Cardiovascular Disease — Payments: $256,557
Cardiovascular Disease $256,557
Dr. Arnold Seto, M.d, M.D
Cardiovascular Disease — Payments: $253,967
Cardiovascular Disease $253,967
Dr. Antonio Halais Frangieh, Md, Mph, MD, MPH
Cardiovascular Disease — Payments: $140,688
Cardiovascular Disease $140,688
Aidan Raney, M.d, M.D
Cardiovascular Disease — Payments: $113,297
Cardiovascular Disease $113,297
Jay Lee, M.d, M.D
Cardiovascular Disease — Payments: $89,034
Cardiovascular Disease $89,034